Literature DB >> 25130114

Marked elevation of serum hyaluronan levels in collagenofibrotic glomerulopathy.

Shunsuke Goto1, Kentaro Nakai, Jun Ito, Hideki Fujii, Kazuyuki Tasaki, Toshiaki Suzuki, Kei Fukami, Shigeo Hara, Shinichi Nishi.   

Abstract

Collagenofibrotic glomerulopathy is a rare glomerular disease characterized by the massive deposition of type III collagen in mesangial and subendothelial spaces. We observed markedly increased serum hyaluronan levels in patients with collagenofibrotic glomerulopathy; levels in three patients were more than 1,000-times greater than the normal upper limit. However, one kidney transplant patient had normal serum hyaluronan levels. We found that serum levels and activities of the enzyme hyaluronidase were normal, and hyaluronan was not markedly deposited in the mesangial or subendothelial spaces. Our findings suggest that serum hyaluronan levels may be a specific diagnostic marker of collagenofibrotic glomerulopathy, and kidney transplantation may alleviate marked increases in serum hyaluronan.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25130114     DOI: 10.2169/internalmedicine.53.2412

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  1 in total

1.  Collagenofibrotic Glomerulopathy.

Authors:  Masato Miyake; Kan Katayama; Takashi Ehara; Yoshikazu Sado; Shunpei Nawa; Tomohiro Murata; Yasuhide Mizutani; Kensuke Joh; Masaaki Ito; Kaoru Dohi
Journal:  Intern Med       Date:  2020-10-14       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.